Sermorelin

Sermorelin – Research-Grade Growth Hormone–Releasing Factor (GRF 1–29)

Sermorelin is a synthetic peptide corresponding to the first 29 amino acid residues of endogenous human growth hormone–releasing factor (GRF). As a truncated fragment, it retains the core structural features required for receptor interaction while remaining distinct from full-length regulatory proteins. In laboratory research settings, Sermorelin is utilized as a reference material for studying GRF-mediated signaling behavior, peptide–receptor interaction models, and comparative analyses involving growth hormone–releasing peptides.

Due to its linear structure and defined amino acid sequence, Sermorelin exhibits physicochemical properties that differ from longer hypothalamic peptides and protein hormones. This allows researchers to investigate receptor activation dynamics, peptide stability, and degradation pathways in vitro without the complexity introduced by extended peptide chains or carrier modifications. Its reproducible synthetic profile supports controlled use in mechanistic assays, comparative peptide studies, and exploratory biochemical research conducted under controlled laboratory conditions.